We have identified a very early stage of B lineage cells in the CD45R (B220)+CD24 (HSA) pre-pro-B fraction of mouse bone marrow delineated by expression of AA4.1, a molecule found on stem cells and early B lineage cells. These cells are B lineage precursors based on their capacity to generate B lineage cells rapidly in stromal-dependent culture and their expression of high levels of germline IgH transcripts in the absence of Rag-1/2. Half of these AA4.1+ precursors express low levels of CD4, characteristic of lymphoid progenitors, but few if any have up-regulated CD19, a molecule expressed very early in the B lineage. Furthermore, expression of genes encoding pre-B and B cell receptor components (mb-1, B29, and lambda 5) and transcription factors necessary for B lineage differentiation (BSAP, E12, E47, and Id) provide further support for designating these cells as the earliest B cell precursors.
SummaryWe have examined at the molecular level the CDR3 and adjacent regions in peripheral blood B lymphocytes of normal individuals. A total of 111 sequences (12-28 sequences from six individuals) were obtained after cloning of the polymerase chain reaction-amplified segments into plasmids or phage . The average length of the VDJ joining was 109 nucleotides, with a range from 79 to 151 . Approximately 75% of the sequences were in frame when translated into amino acids . Among the JH segments, J H4 was found most frequently (in 52 .5% of the sequences), and JH 1 and JH 2 segments the least frequently (-I% of the clones) . A polymorphic JH6 gene with a one-codnn deletion accompanied by a base change was present in two of six patients. Preferential breakpoints were found for JH 2, J.3, J 4, and Jx5, although the breakpoints of JH6 were distributed more heterogenously.In -90% of the cases, significant homology of the D regions with published D sequences was found . Preferential usage of a particular coding frame was observed in in-frame sequences utilizing DA, D21/9, and DMl segments. However, in general, all coding frames of germline D genes were used to generate CDR3s . Eight sequences that have a DN1-like D sequence with two base changes at the same positions were identified, suggesting the likely existence of a new germ line D gene belonging to the DN families. Using probes specific for a particular CDR3, the frequency of a specific B cell clone in the peripheral blood of normal individuals was estimated to be at most as high as 1/20,000 .T he most variable region of the immunoglobulin heavy chain is the third complementarity determining region (CDR3) (1, 2) . This region spans the junction between the variable (V ) diversity (D), and junctional 0,,) segments in the rearranged IgH genes (1, 2) . The hypervariability of this region is due to the combinatorial assortment of the many V , D, and JH segments that are utilized to generate a particular CDR3, to the imprecise joining mechanisms that include deletion of bases from the potential coding regions of each segment to be joined (3), and the addition of new bases that can be enzymatically added at the point of joining (N regions) (4) . Finally, somatic mutations of the rearranged region can contribute to the production of higher affinity antibodies (5) .The nucleotide sequences of all the human D genes, estimated to be -30 in number (6), have not been fully defined, and questions remain about the relative usage of different D genes used in VDJjoinings during development and in adult individuals . Furthermore, the characteristics of the extent of base excision and addition, including the identification of preferred sequence boundaries for the V., D, and J regions, have not been well delineated. The relative frequency of inframe translation products reflecting productive rearrangements, and the possibility of specific translation frames being preferred for particular D gene families have not been determined on a large sample size.To address these questions, we ha...
acute lymphoblastic leukemia ͉ mTOR ͉ rapamycin ͉ IL-7
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.